Auour Investments LLC Tyra Biosciences, Inc. Call Options Transaction History
Auour Investments LLC
- $266 Million
- Q2 2024
Call Options
0 transactions
Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
---|
Others Institutions Holding TYRA
# of Institutions
76Shares Held
32.4MCall Options Held
600Put Options Held
3.7K-
Boxer Capital, LLC San Diego, CA6.45MShares$139 Million5.5% of portfolio
-
Bvf Inc San Francisco, CA4.66MShares$101 Million2.29% of portfolio
-
Canaan Partners Xi LLC Menlo Park, CA4.41MShares$95.1 Million85.38% of portfolio
-
Nextech Invest Ag4.06MShares$87.5 Million12.44% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA1.99MShares$42.9 Million3.43% of portfolio
About Tyra Biosciences, Inc.
- Ticker TYRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,973,600
- Market Cap $905M
- Description
- Tyra Biosciences, Inc., a preclinical-stage biopharmaceutical company, focuses on developing therapies to overcome tumor resistance and enhance outcomes for patients with cancer. Its lead product candidate is TYRA-300, a selective inhibitor of fibroblast growth factor receptor (FGFR)3 for the treatment of muscle invasive bladder cancer. The comp...